On 28 October 2026, Mochida Pharmaceutical published disclosure materials announcing the execution of a comprehensive partnership agreement relating to biosimilars. The materials are available for download in PDF format.
On 28 October 2026, Mochida Pharmaceutical's disclosure material, “Notice regarding the execution of a comprehensive partnership agreement relating to biosimilars,” became available for viewing and was published under the company's name.
The material states that the company had executed a comprehensive partnership agreement relating to biosimilars and indicates that further details are provided in the disclosure material in PDF format.
This article cites reporting by The Nikkei as supporting coverage and directs readers to download the disclosure material in PDF format.